Five Prime Therapeutics

Five Prime Therapeutics Newswire

Comprehensive Real-Time News Feed for Five Prime Therapeutics.

Results 1 - 20 of 60 in Five Prime Therapeutics

  1. Five Prime Therapeutics, Inc. Announces First Quarter 2015 Financial ResultsRead the original story

    Wednesday May 13 | BioSpace

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today provided a corporate update and reported financial results for the first quarter ending March 31, 2015. "We made important progress in all of our programs during the first quarter of 2015 and remain on track to deliver on a number of key milestones over the next 12 months," said Lewis T. "Rusty" Williams, M.D., Ph.D., Founder and Chief Executive Officer of Five Prime.

    Comment?

  2. Five Prime Therapeutics' (FPRX) CEO Lewis Williams on Q1 2015 Results - Earnings Call TranscriptRead the original story w/Photo

    Wednesday May 13 | Seeking Alpha

    Good day, ladies and gentlemen, and welcome to the Five Prime Therapeutics 2015 Q1 quarterly earnings call. [Operator Instructions] I would now like to introduce your host for today's conference, Aron Knickerbocker, Chief Business Officer for Five Prime.

    Comment?

  3. Five Prime Therapeutics, Inc. To Announce First Quarter 2015...Read the original story

    Thursday May 7 | BioSpace

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, will report its first quarter financial results on Wednesday, May 13, 2015, after the U.S. financial markets close. Five Prime will host a conference call and live audio webcast on Wednesday, May 13, 2015 at 5:00 p.m. /2:00 p.m. to discuss the company's financial results and provide a general business update.

    Comment?

  4. Roche nominates Smith & Nephew CFO to boardRead the original story w/Photo

    Friday May 8 | MarketWatch

    Roche Holding AG said Friday it was nominating the chief financial officer of medical equipment maker Smith & Nephew PLC to its board of directors after long-serving member Dame DeAnne Julius chose not to run for re-election. Basel-based Roche said its board had nominated Julie Brown to replace Dame Julius, who has served since 2002.

    Comment?

  5. Five Prime Therapeutics, Inc. To Present At The Antibody DayRead the original story

    Sunday May 3 | BioSpace

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Aron Knickerbocker, Chief Business Officer, and Brian Wong, Vice President, Research and Head of Immuno-Oncology, will present at the Credit Suisse Antibody Day on Wednesday, May 6 at 3:00 PM Eastern Daylight Time. The conference will take place at Credit Suisse's offices at One Madison Avenue, New York City.

    Comment?

  6. Five Prime Therapeutics to Present at the Credit Suisse Antibody DayRead the original story w/Photo

    Friday May 1 | GlobeNewswire

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Aron Knickerbocker, Chief Business Officer, and Brian Wong, Vice President, Research and Head of Immuno-Oncology, will present at the Credit Suisse Antibody Day on Wednesday, May 6 at 3:00 PM Eastern Daylight Time. The conference will take place at Credit Suisse's offices at One Madison Avenue, New York City.

    Comment?

  7. Five Prime Therapeutics, Inc. To Host Research & Development Day On May 5, 2015Read the original story

    Wednesday Apr 22 | BioSpace

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that the company will hold its first Research & Development Day event for the institutional investment community in New York City on May 5, 2015. The formal program and webcast will begin at 8:30 am ET and will conclude at approximately 11:45 am ET.

    Comment?

  8. Five Prime Therapeutics to Host Research & Development Day on May 5, 2015Read the original story w/Photo

    Wednesday Apr 22 | GlobeNewswire

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that the company will hold its first Research & Development Day event for the institutional investment community in New York City on May 5, 2015. The formal program and webcast will begin at 8:30 am ET and will conclude at approximately 11:45 am ET.

    Comment?

  9. Roche Revenue Lifted by Cancer DrugsRead the original story w/Photo

    Tuesday Apr 21 | Wall Street Journal

    Roche Holding AG posted a 3% rise in first-quarter revenue as the Swiss pharmaceutical giant reported strong growth of its core franchise of cancer drugs. Basel-based Roche said sales rose to 11.83 billion Swiss francs in the quarter ended March 31, beating an analyst forecast of 11.508 billion francs.

    Comment?

  10. Roche Breast-Cancer Drug Challenges Merck in Immunotherapy RaceRead the original story

    Apr 20, 2015 | The Washington Post

    Roche Holding AG reported favorable test results for a breast-cancer medicine, intensifying a neck-and- neck race with Merck & Co. to develop immunotherapies that harness the body's own defense mechanisms to fight the disease.

    Comment?

  11. AnaptysBio, Inc. Recruits Ex-Pfizer R&D Star to Lead Translational BiologyRead the original story

    Apr 6, 2015 | BioSpace

    ... across emerging inflammation and immuno-oncology applications." Dr. Los joins AnaptysBio from Five Prime Therapeutics, where he led translational medicine across several immuno-oncology related biologics. Prior to Five Prime, Dr. Los was head of ...

    Comment?

  12. The Global Deflationary TsunamiRead the original story w/Photo

    Mar 20, 2015 | Daily Kos

    Every few years an economic event will happen that can be easily seen by everyone except mainstream economists. Today that economic event is a global tidalwave of deflation that is sweeping the globe.

    Comment?

  13. Five Prime Therapeutics, Inc. Announces Fourth Quarter And Full Year 2014 Financial ResultRead the original story

    Mar 17, 2015 | BioSpace

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today provided a corporate update and reported financial results for the fourth quarter and full year ending December 31, 2014. "2014 was a remarkable year for Five Prime," said Lewis T. "Rusty" Williams, M.D., Ph.D., Founder and Chief Executive Officer of Five Prime.

    Comment?

  14. Five Prime Therapeutics Announces Fourth Quarter and Full Year 2014 Financial ResultsRead the original story w/Photo

    Mar 17, 2015 | GlobeNewswire

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today provided a corporate update and reported financial results for the fourth quarter and full year ending December 31, 2014. "2014 was a remarkable year for Five Prime," said Lewis T. "Rusty" Williams, M.D., Ph.D., Founder and Chief Executive Officer of Five Prime.

    Comment?

  15. Five Prime Therapeutics, Inc. To Announce Fourth Quarter And Full...Read the original story

    Mar 10, 2015 | BioSpace

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, will report its fourth quarter and full year 2014 financial results on Tuesday, March 17, 2015, after the U.S. financial markets close. Five Prime will host a conference call and live audio webcast on Tuesday, March 17, 2015 at 5:00 p.m. /2:00 p.m. to discuss the company's financial results and provide a general business update.

    Comment?

  16. Five Prime Therapeutics, Inc. To Present At The Global Healthcare ConferenceRead the original story

    Mar 5, 2015 | BioSpace

    Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Julie Hambleton, M.D., Chief Medical Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 12, 2015 at 1:05 PM Eastern Daylight Time. The conference will take place at the Loews Miami Beach Hotel.

    Comment?

  17. Three Reasons Why The Bay Area Beats Other Biotech HubsRead the original story

    Feb 24, 2015 | BioSpace

    BayBio, the longtime Northern California life sciences trade group, is in the final days before it merges with the California Healthcare Institute to give the biotech industry a bigger voice in Sacramento and Washington, D.C. But Gail Maderis, who shepherded the organization for more than five years after stepping down as CEO of Five Prime Therapeutics Inc., isn't backing down. With a figurative foam "We're #1" finger on her hand, in her final letter to BayBio members, Maderis shuns the "Top 10" lists and outlines why the Bay Area beats other regional biotech hubs.

    Comment?

  18. BayBio boss' goodbye: 3 reasons why the Bay Area beats other biotech hubsRead the original story w/Photo

    Feb 24, 2015 | Business Journal

    BayBio, the longtime Northern California life sciences trade group, is in the final days before it merges with the California Healthcare Institute to give the biotech industry a bigger voice in Sacramento and Washington, D.C. But Gail Maderis, who shepherded the organization for more than five years after stepping down as CEO of Five Prime Therapeutics Inc., isn't backing down. With a figurative foam "We're #1" finger on her hand, in her final letter to BayBio members , Maderis shuns the "Top 10" lists and outlines why the Bay Area beats other regional biotech hubs.

    Comment?

  19. Scientists unveil map of 'epigenome,' a second genetic codeRead the original story w/Photo

    Feb 18, 2015 | CNews

    Scientists for the first time have mapped out the molecular "switches" that can turn on or silence individual genes in the DNA in more than 100 types of human cells, an accomplishment that reveals the complexity of genetic information and the challenges of interpreting it. Researchers unveiled the map of the "epigenome" in the journal Nature on Wednesday, alongside nearly two dozen related papers.

    Comment?

  20. Beyond DNA: 'Second genetic code' that turns genes on and off mappedRead the original story w/Photo

    Feb 18, 2015 | CBC News

    Linda Lewis, right, and Leora Eisen are identical twins who were featured in the documentary Two of a Kind, which examines the differences between identical twins. Many of those differences are due to the epigenome, a "second genetic code" of switches that turn genes on and off.

    Comment?